Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Timely diagnosis remains an unmet need in non-neutropenic patients at risk for
aspergillosis, including those with COVID-19-associated pulmonary aspergillosis (CAPA) …

Rationale: Invasive pulmonary aspergillosis has emerged as a frequent coinfection in
severe coronavirus disease (COVID-19), similarly to influenza, yet the clinical invasiveness …

COVID-19 pandemic highlighted the complications of secondary fungal infections that
occurred globally in severe cases of coronavirus disease managed in the intensive care …

Introduction Over the last years, severe respiratory viral infections, particularly those caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the influenza virus …

Purpose COVID-19 associated pulmonary aspergillosis (CAPA) is associated with increased
morbidity and mortality in ICU patients. We investigated the incidence of, risk factors for and …

Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary
aspergillosis (CAPA) are increasingly recognised as important complications in patients …

There has been significant increase in the use of molecular tools for the diagnosis of
invasive aspergillosis (IA) and mucormycosis. However, their range of detection may be too …

The COVID-19 pandemic has highlighted the detrimental effect of secondary pathogens in
patients with a primary viral insult. In addition to superinfections with bacterial pathogens …